David F. Pfeiffer

Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA.

Orthoforge, Inc. provides healthcare providers with a new way to assess bone and soft tissue healing. The private company is based in an undisclosed location and was founded by Erik Hall and Brent Nowak, with Brent Nowak serving as CEO since incorporation. The American company's proprietary system monitors and tracks healing without the need for radiation exposure from technologies like x-ray and CT scans.

CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA.

Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK.

CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE.

Ellman International, Inc. manufactures surgical devices and provides radiosurgery education and training programs. Its products include aesthetics, surgical, veterinary and dental. The company was founded in 1959 and is headquartered in Hicksville, NY.

Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.